Related Experiment Videos

Improving 1-year outcome in first-episode psychosis: OPUS trial

Lone Petersen1, Merete Nordentoft, Pia Jeppesen

  • 1Department of Psychiatry, Bispebjerg Hospital, Bispebjerg Bakke 23, DK-2400 Copenhagen NV, Denmark. lonepetersen@mail.dk

The British Journal of Psychiatry. Supplement
|August 2, 2005
PubMed

Insights

Integrated treatment significantly improved outcomes for patients with first-episode psychosis, reducing poor clinical and social functioning compared to standard care. This approach is vital for early schizophrenia-spectrum disorder management.

Area of Science:

  • Psychiatry and Mental Health
  • Clinical Psychology
  • Schizophrenia Research

Background:

  • Early intervention is crucial for long-term outcomes in schizophrenia-spectrum disorders.
  • Addressing poor outcomes during the critical early period of illness is essential.
  • First-episode psychosis represents a key window for therapeutic impact.

Purpose of the Study:

  • To compare the effectiveness of integrated treatment versus standard treatment.
  • To evaluate the reduction in poor clinical and social outcomes after one year.
  • To determine if integrated treatment benefits patients with first-episode psychosis.

Main Methods:

  • A randomized controlled trial involving 547 patients with first-episode psychosis.
  • Patients were assigned to either integrated treatment (n=275) or standard treatment (n=272).
  • Assessment of psychotic symptoms and social functioning was conducted at one year.

Main Results:

  • Integrated treatment showed a significant beneficial effect on "any poor outcome" compared to standard treatment.
  • Patients with schizophrenia receiving integrated treatment experienced significantly better outcomes.
  • A reduction in poor clinical and social outcomes was observed in the integrated treatment group.

Conclusions:

  • Integrated treatment significantly reduces the proportion of patients experiencing poor clinical and social outcomes.
  • This approach offers a more effective strategy for managing early psychosis.
  • Early integrated treatment is recommended for improving long-term prognosis in schizophrenia-spectrum disorders.
Abstract

Related Concept Videos

Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
Psychosis and Antipsychotic Drugs: Overview01:28

Psychosis and Antipsychotic Drugs: Overview

The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic symptoms in all...
Guidelines for Writing Outcome01:11

Guidelines for Writing Outcome

When developing expected outcomes for a patient care plan, the nurse should adhere to the following recommendations:
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care evaluation by...